Ulipristal acetate for use in moderate to severe symptoms of uterine fibroids

被引：0
|
作者：
Talaulikar, Vikram Sinai [1 ]
Manyonda, Isaac [1 ]
机构：
[1] St Georges Hosp & Univ London, London SW17 0RE, England
来源：
WOMENS HEALTH | 2014年 / 10卷 / 06期
关键词：
fibroids; medical; myoma; SPRM; ulipristal acetate;
D O I：
10.2217/WHE.14.60
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Although it has been known for a long time that uterine fibroids respond to changes in sex steroid concentrations, it is the availability of selective progesterone receptor modulators such as ulipristal acetete that has provided the gynecologist with a novel option for medical management of uterine fibroids. Ulipristal acetate is presently licensed in Europe for use in women with symptomatic fibroids up to 3 months prior to surgery and has demonstrated good clinical efficacy and safety for this indication. Future trials will define the long-term safety of this drug and its role in medical management of uterine fibroids.
引用
收藏
页码：565 / 570
页数：6
相关论文
共 50 条
  • [1] ECONOMIC EVALUATION OF ULIPRISTAL ACETATE FOR THE TREATMENT OF PATIENTS WITH MODERATE AND SEVERE SYMPTOMS OF UTERINE FIBROIDS IN ROMANIA
    Lorenzovici, L.
    Szekely, A.
    Agh, T.
    Vamossy, I
    Kelemen, L. J.
    Finta, H.
    Kalo, Z.
    VALUE IN HEALTH, 2014, 17 (07) : A510 - A510
  • [2] ECONOMIC EVALUATION OF ULIPRISTAL ACETATE TABLETS FOR THE TREATMENT OF PATIENTS WITH MODERATE AND SEVERE SYMPTOMS OF UTERINE FIBROIDS
    Nagy, B.
    Timar, G.
    Jozwiak-Hagymasy, J.
    Kovacs, G.
    Meresz, G.
    Vamossy, I
    Agh, T.
    Laszlo, A.
    Voko, Z.
    Kalo, Z.
    VALUE IN HEALTH, 2012, 15 (07) : A540 - A540
  • [3] The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids
    Nagy, Balazs
    Timar, Gyoergy
    Jozwiak-Hagymasy, Judit
    Kovacs, Gabor
    Meresz, Gergo
    Vamossy, Istvan
    Agh, Tomas
    Laszlo, Adam
    Voko, Zoltan
    Kalo, Zoltan
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2014, 175 : 75 - 81
  • [4] ECONOMIC EVALUATION OF ULIPRISTAL ACETATE FOR THE TREATMENT OF PATIENTS WITH MODERATE AND SEVERE SYMPTOMS OF UTERINE FIBROIDS BEFORE SURGERY IN MEXICO
    Paladio-Hernandez, J. A.
    Rosas, R.
    Pozo, L.
    Del Cid, O.
    Robles-Valencia, J. A.
    VALUE IN HEALTH, 2015, 18 (07) : A834 - A834
  • [5] Ulipristal acetate in uterine fibroids
    Galliano, Daniela
    FERTILITY AND STERILITY, 2015, 103 (02) : 359 - 360
  • [6] Ulipristal Acetate In Uterine Fibroids
    Croxtall, Jamie D.
    DRUGS, 2012, 72 (08) : 1075 - 1085
  • [7] Ulipristal acetate: a guide to its use in uterine fibroids
    Katherine A. Lyseng-Williamson
    Jamie D. Croxtall
    Drugs & Therapy Perspectives, 2012, 28 (9) : 1 - 4
  • [8] Effect of Ulipristal Acetate for Uterine Fibroids
    Deshpande, Preeti Suhas
    Deshpande, Suhas Suresh
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2019, 8 (49): : 3675 - 3678
  • [9] Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids
    Donnez, Jacques
    Hudecek, Robert
    Donnez, Olivier
    Matule, Dace
    Arhendt, Hans-Joachim
    Zatik, Janos
    Kasilovskiene, Zaneta
    Dumitrascu, Mihai Cristian
    Fernandez, Herve
    Barlow, David H.
    Bouchard, Philippe
    Fauser, Bart C. J. M.
    Bestel, Elke
    Terrill, Paul
    Osterloh, Ian
    Loumaye, Ernest
    FERTILITY AND STERILITY, 2015, 103 (02) : 519 - 527
  • [10] Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids
    Donnez, Jacques
    Tomaszewski, Janusz
    Vazquez, Francisco
    Bouchard, Philippe
    Lemieszczuk, Boguslav
    Baro, Francesco
    Nouri, Kazem
    Selvaggi, Luigi
    Sodowski, Krzysztof
    Bestel, Elke
    Terrill, Paul
    Osterloh, Ian
    Loumaye, Ernest
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (05): : 421 - 432
12345